We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601127:SSESeres Group Co. Ltd. Class A Analysis

Data as of 2026-06-01 - not real-time

CN¥80.25

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Seres Group is trading at CNY 80.25, well below its 20‑day (84.58) and 50‑day (89.11) SMAs and approaching the identified support at 77.77, suggesting a potential short‑term bounce. The RSI of 37.6 points to a modestly oversold condition, while the MACD histogram turned positive, giving a bullish signal despite the broader bearish trend. Volatility remains elevated at 34% over the past 30 days, and the stock’s beta is near zero, indicating limited market‑wide correlation but heightened price swings. On the valuation side, the forward P/E of 7.9 and a DCF‑derived fair value of roughly CNY 248 imply the market is pricing the company at a deep discount relative to its earnings potential.
Fundamentally, revenue surged 34.5% YoY to CNY 171.7 bn, yet margins stay thin (operating margin ≈3.5%). The company holds ample cash (CNY 64.1 bn) versus modest debt (CNY 4.4 bn) and pays a 1.36% dividend with a 35.6% payout ratio, supporting dividend sustainability. Recent news highlights a strategic shift toward new‑energy vehicles as ICE sales slump 46% year‑over‑year, aligning Seres with the core trajectory of the global auto industry.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with limited upside
  • Bullish MACD crossover amid high volatility
  • Increasing trading volume indicating potential short‑term interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and shift to NEV platform
  • Forward P/E of 7.9 and DCF fair value far above current price
  • Sustainable dividend with comfortable payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Structural industry transition toward electric vehicles
  • Robust cash position and low net debt enhancing financial flexibility
  • Undervalued valuation metrics offering significant upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth34.50%
Profit Margin3.47%
P/E Ratio22.3
ROE18.50%
ROA3.89%
Debt/Equity10.39
P/B Ratio3.4
Op. Cash FlowCN¥15.6B
Free Cash FlowCN¥10.3B

Technical Analysis

TrendBearish
RSI37.6
SupportCN¥77.77
ResistanceCN¥92.90
MA 20CN¥84.58
MA 50CN¥89.11
MA 200CN¥119.35
MACDBullish
VolumeIncreasing
Fear & Greed Index94.07

Valuation

Fair ValueCN¥248.56
GradeUndervalued
TypeBlend
Dividend Yield1.36%

Risk Assessment

Beta0.07
Volatility34.25%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.